Published in Br J Cancer on June 27, 2006
Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis. Diagn Pathol (2012) 1.36
Diagnostic utility of galectin-3 in thyroid cancer. Am J Pathol (2010) 1.14
Ultrasound-guided core-needle biopsy in thyroid nodules. A study of 676 consecutive cases with surgical correlation. Eur Radiol (2015) 0.91
Are risk factors common to thyroid cancer and nodule? A forty years observational time-trend study. PLoS One (2012) 0.83
Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3. PLoS One (2008) 0.81
Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis. Int J Mol Sci (2017) 0.78
Does large needle aspiration biopsy add pain to the thyroid nodule evaluation? PLoS One (2013) 0.76
Serum Galectin-3: diagnostic value for papillary thyroid carcinoma. Ulus Cerrahi Derg (2015) 0.75
Hemithyroidectomy is the preferred initial operative approach for an indeterminate fine needle aspiration biopsy diagnosis. Can J Surg (2012) 0.75
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2006) 12.23
Management of a solitary thyroid nodule. N Engl J Med (1993) 7.15
Galectins as modulators of tumour progression. Nat Rev Cancer (2005) 5.30
BIOPSY BY NEEDLE PUNCTURE AND ASPIRATION. Ann Surg (1930) 5.27
Improving accuracy of cytology for nodular thyroid lesions. Lancet (2000) 2.99
Nodular thyroid disease. Evaluation and management. N Engl J Med (1985) 2.41
Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology (2004) 1.60
Aspiration biopsy of thyroid nodules. Surg Gynecol Obstet (1973) 1.60
Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents. J Clin Endocrinol Metab (2002) 1.54
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet (2001) 1.54
Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc (1994) 1.49
Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology (2005) 1.41
Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol (2005) 1.37
Fine-needle aspiration of thyroid: an institutional experience. Thyroid (1998) 1.30
Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer (2000) 1.28
Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res (1998) 1.18
Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer (2005) 1.14
Malignant transformation of thyroid follicular cells by galectin-3. Cancer Lett (2003) 1.13
Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Int J Oncol (2001) 1.09
Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential. Mod Pathol (2005) 1.07
Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med (2002) 1.07
The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer. Am J Clin Pathol (2004) 1.05
Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg (2004) 1.03
Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer (1999) 1.02
The role of fine-needle aspiration biopsy in the management of thyroid nodules in children, adolescents, and young adults: a multi-institutional study. Thyroid (1999) 0.96
Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions. Head Neck (2004) 0.93
Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis. J Pathol (2001) 0.92
Needle aspiration techniques in preoperative selection of patients with thyroid nodules: a long-term study. J Clin Oncol (1996) 0.92
Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. Br J Cancer (2005) 0.90
Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab (2002) 0.90
Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry. Mod Pathol (2003) 0.88
Increasing the accuracy of fine-needle biopsy for thyroid nodules. Arch Pathol Lab Med (1989) 0.88
Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol (1999) 0.87
Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn Cytopathol (2002) 0.87
Galectin-3 is not useful in thyroid FNA. Cytopathology (2005) 0.87
Immunohistochemical markers of thyroid tumors: significance and diagnostic applications. Tumori (2004) 0.87
A logistic model for thyroid lesions. Diagn Cytopathol (1992) 0.86
The value of thyroid peroxidase immunohistochemistry for preoperative fine-needle aspiration diagnosis of the follicular variant of papillary thyroid cancer. Surgery (1999) 0.86
Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule. Biomed Pharmacother (2005) 0.86
Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule. Clin Endocrinol (Oxf) (2000) 0.85
Fine needle aspiration cytology of the thyroid. Clin Lab Med (1998) 0.82
Practice, efficacy, and costs of thyroid nodule evaluation: a retrospective study in a Dutch university hospital. Thyroid (2004) 0.82
Large-needle aspiration biopsy for the preoperative selection of palpable thyroid nodules diagnosed by fine-needle aspiration as a microfollicular nodule or suspected cancer. Am J Clin Pathol (2000) 0.81
Large needle aspiration biopsy for reducing the rate of inadequate cytology on fine needle aspiration specimens from palpable thyroid nodules. Biomed Pharmacother (1998) 0.81
Fine-needle aspiration of thyroid follicular neoplasm: diagnostic use of thyroid peroxidase immunocytochemistry with monoclonal antibody 47. Surgery (1994) 0.81
From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules. Biomed Pharmacother (2004) 0.80
Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. Pol J Pathol (2003) 0.80
Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma. Arch Surg (2004) 0.78
Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology (2006) 0.78
[Low galectin-3 capacity to discriminate thyroid lesions]. Rev Invest Clin (2005) 0.77
The management of differentiated thyroid cancer in Europe in 1988. Results of an international survey. Acta Endocrinol (Copenh) (1989) 0.76
Methodological considerations regarding the use of galectin-3 expression analysis in preoperative evaluation of thyroid nodules. J Clin Endocrinol Metab (2003) 0.76
Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst (1988) 5.42
Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes (2000) 3.01
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling. Ann Oncol (2009) 2.13
Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol (1998) 2.09
Effects of dopamine and noradrenaline on Ca channels of cultured sensory and sympathetic neurons of chick. Pflugers Arch (1986) 2.02
Thyroid disease classification. Lancet (2000) 2.00
Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol (2004) 1.88
Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res (1997) 1.85
Multiple squamous cell carcinomas of the oral cavity in a young patient with graft-versus-host disease following allogenic bone marrow transplantation. Int J Oral Maxillofac Surg (2010) 1.83
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol (2009) 1.78
Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res (1988) 1.75
Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid (1998) 1.75
Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood (2001) 1.67
Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer. Clin Endocrinol (Oxf) (2007) 1.66
Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J Pathol (1994) 1.65
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res (1998) 1.54
Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol (1995) 1.43
Predictive Role of p53 Protein as a Single Marker or Associated to Ki67 Antigen in Oral Carcinogenesis. Open Dent J (2008) 1.42
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst (1997) 1.41
Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype. J Pathol (1996) 1.40
Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT). Int J Biol Markers (2002) 1.40
Can growth hormone treatment in boys without growth hormone deficiency impair testicular function? J Pediatr (1999) 1.40
Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol (1995) 1.40
Dosimetric considerations on multiple arc stereotaxic radiotherapy. Radiother Oncol (1988) 1.39
Head and neck cancer in elderly patients: is microsurgical free-tissue transfer a safe procedure? Acta Otorhinolaryngol Ital (2012) 1.38
The NM23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with BglII. Genes Chromosomes Cancer (1992) 1.34
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet (2004) 1.33
Small cell lung cancer. Ann Oncol (2006) 1.30
Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. Eur J Cancer (1995) 1.27
Interchromosomal effect in sperm of males with translocations: report of 6 cases and review of the literature. Int J Androl (2005) 1.22
Expression of CD38 increases intracellular calcium concentration and reduces doubling time in HeLa and 3T3 cells. J Biol Chem (1998) 1.22
p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study. Br J Cancer (1997) 1.21
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer (2013) 1.21
Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer (1995) 1.19
Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer (1991) 1.15
Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother (2009) 1.14
Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis. Am J Physiol (1990) 1.13
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib. Br J Cancer (2008) 1.10
External stereotactic irradiation by linear accelerator. Neurosurgery (1985) 1.10
Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents. Seizure (2001) 1.09
Evidence for gene conversion in the generation of extensive polymorphism in the promoter of the growth hormone gene. Hum Genet (1997) 1.08
Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ (2001) 1.08
Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit. Arch Gerontol Geriatr (2007) 1.08
A special case of bilateral ovarian metastases in a woman with papillary carcinoma of the thyroid. Exp Clin Endocrinol Diabetes (2007) 1.08
Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression. Int J Cancer (1993) 1.07
Hemodynamic and metabolic impairment in acute pancreatitis. World J Surg (1981) 1.07
Cognition in action: testing a model of limb apraxia. Brain Cogn (2000) 1.06
Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br J Cancer (1997) 1.06
Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol (1987) 1.06
p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene (1996) 1.05
Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer. Dis Markers (1999) 1.05
Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer (1995) 1.05
Unusual presentation of obstructive sleep apnoea syndrome due to a giant mandible osteoma: case report and literature review. Acta Otorhinolaryngol Ital (2013) 1.05
p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br J Cancer (1996) 1.04
Membrane currents of identified isolated rat corticotropes and gonadotropes. Am J Physiol (1987) 1.04
Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma. Eur J Cancer (1998) 1.04
New technique for three-dimensional linear accelerator radiosurgery. Acta Neurochir Suppl (Wien) (1987) 1.03
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res (2002) 1.02
Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis. Br J Cancer (2004) 1.02
Hemiplegic atrophy. Morphological findings in the anterior tibial muscle of patients with cerebral vascular accidents. Acta Neuropathol (1984) 1.02
Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression. Int J Cancer (1997) 1.02
Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes (Lond) (2009) 1.02
MMTV-like sequences in human breast cancer: a fluorescent PCR/laser microdissection approach. J Pathol (2006) 1.02
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. J Pathol (2001) 1.01
Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact. Cancer Res (2000) 1.01
mdm2 gene alterations and mdm2 protein expression in breast carcinomas. J Pathol (1995) 1.01
Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-gamma. Am J Physiol Lung Cell Mol Physiol (2000) 1.01
Early diagnosis of bacterial infection in the neonate. J Matern Fetal Neonatal Med (2004) 1.01
The Istituto Rizzoli-Beretta experience with osteosarcoma of the jaw. Cancer (1991) 1.00
Vascular pedicle ossification of free fibular flap: is it a rare phenomenon? Is it possible to avoid this risk? Acta Otorhinolaryngol Ital (2013) 1.00
Right-sided anarchic (alien) hand: a longitudinal study. Neuropsychologia (1991) 1.00
Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer. Gynecol Oncol (1999) 1.00
Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs. Eur J Neurosci (1997) 0.99
HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage. Cell Prolif (2009) 0.99
Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas. Br J Cancer (1999) 0.98
Human population dynamics revisited with the logistic model: how much can be modeled and predicted? Technol Forecast Soc Change (1996) 0.98
Histochemical and ultrastructural aspects of m. vastus lateralis in sedentary old people (age 65--89 years). Acta Neuropathol (1980) 0.98
Detection of p53 mutations by single-strand conformation polymorphisms (SSCP) gel electrophoresis. A comparative study of radioactive and nonradioactive silver-stained SSCP analysis. Diagn Mol Pathol (1995) 0.98
Effects of pulsed electromagnetic fields on articular hyaline cartilage: review of experimental and clinical studies. Biomed Pharmacother (2005) 0.97
Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans. Horm Metab Res (1999) 0.97
HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage. Oncogene (2011) 0.97
Automatic morphometric analysis of skeletal muscle fibers in the aging man. Anat Rec (1987) 0.97
67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas. Clin Cancer Res (1997) 0.96
Mapping a dominant form of multinodular goiter to chromosome Xp22. Am J Hum Genet (2000) 0.96
NM23 gene expression correlates with cell growth rate and S-phase. Int J Cancer (1995) 0.96
Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin Cancer Res (1999) 0.96
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells. Br J Cancer (2005) 0.96
mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations. Diagn Mol Pathol (1995) 0.95
Acute renal failure after isolated CABG surgery: six years of experience. Minerva Anestesiol (2007) 0.95
Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer. Ann Oncol (2003) 0.95
Association of HLA class I and class II antigen expression and mortality in uveal melanoma. Invest Ophthalmol Vis Sci (2001) 0.95
FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations. J Pathol (1998) 0.95